The diagnostic value of endoscopy and Helicobacter pylori tests for peptic ulcer patients in late post-treatment setting by Maaroos, Heidi-Ingrid et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
BMC Gastroenterology
Open Access Research article
The diagnostic value of endoscopy and Helicobacter pylori tests for 
peptic ulcer patients in late post-treatment setting
Heidi-Ingrid Maaroos1, Helena Andreson2, Krista Lõivukene2, Pirje Hütt2, 
Helgi Kolk3, Ingrid Kull3, Katrin Labotkin3 and Marika Mikelsaar*2
Address: 1Department of Family Medicine, Faculty of Medicine, University of Tartu, Estonia, 2Department of Microbiology, Faculty of Medicine, 
University of Tartu, Estonia and 3Department of Internal Medicine, Faculty of Medicine, University of Tartu, Estonia
Email: Heidi-Ingrid Maaroos - Heidi-Ingrid.Maaroos@ut.ee; Helena Andreson - Helena.Andreson@ut.ee; 
Krista Lõivukene - Krista.Loivuke@kliinikum.ee; Pirje Hütt - Pirje.Hutt@ut.ee; Helgi Kolk - Helgi.Kolk@kliinikum.ee; 
Ingrid Kull - Ingrid.Kull@kliinikum.ee; Katrin Labotkin - Katrin.Labotkin@kliinikum.ee; Marika Mikelsaar* - Marika.Mikelsaar@ut.ee
* Corresponding author    
Abstract
Background: Guidelines for management of peptic ulcer patients after the treatment are largely
directed to detection of H. pylori infection using only non-invasive tests. We compared the
diagnostic value of non-invasive and endoscopy based H. pylori tests in a late post-treatment setting.
Methods: Altogether 34 patients with dyspeptic complaints were referred for gastroscopy 5 years
after the treatment of peptic ulcer using a one-week triple therapy scheme. The endoscopic and
histologic findings were evaluated according to the Sydney classification. Bacteriological, PCR and
cytological investigations and 13C-UBT tests were performed.
Results: Seventeen patients were defined H. pylori positive by 13C-UBT test, PCR and histological
examination. On endoscopy, peptic ulcer persisted in 4 H. pylori positive cases. Among the 6 cases
with erosions of the gastric mucosa, only two patients were H. pylori positive. Mucosal atrophy and
intestinal metaplasia were revealed both in the H. pylori positive and H. pylori negative cases.
Bacteriological examination revealed three clarithromycin resistant H. pylori strains. Cytology failed
to prove validity for diagnosing H. pylori in a post-treatment setting.
Conclusions: In a late post-treatment setting, patients with dyspepsia should not be monitored
only by non-invasive investigation methods; it is also justified to use the classical histological
evaluation of H. pylori colonisation, PCR and bacteriology as they have shown good concordance
with 13C-UBT. Moreover, endoscopy and histological investigation of a gastric biopsy have proved
to be the methods with an additional diagnostic value, providing the physician with information
about inflammatory, atrophic and metaplastic lesions of the stomach in dyspeptic H. pylori positive
and negative patients. Bacteriological methods are suggested for detecting the putative
antimicrobial resistance of H. pylori, aimed at successful eradication of infection in persistent peptic
ulcer cases.
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Background
Treatment of peptic ulcer in accordance with relevant
guidelines is becoming a common task for general practi-
tioners [1-6]. In a post-treatment setting, in accordance
with guidelines, prompt check-up of treatment results is
recommended only in gastric ulcer cases with the use of
13C-urea breath test (13C-UBT) [2-5]. In a situation where
patients have clinical symptoms after H. pylori eradication
therapy, endoscopy is favoured in all peptic ulcer cases
[6]. The aim of endoscopy is to establish the reason for
clinical symptoms and to prove presence of peptic ulcer or
malignancies, but also to support physicians and patients
in the understanding of complaints [7]. Moreover, endos-
copy allows determination of persistent H. pylori infection
using endoscopy-based tests. Endoscopic biopsies alone
are not considered adequate for confirming eradication of
bacteria, although they might provide additional infor-
mation about gastritis and dysplasia [8]. Use of more than
one method in testing gastric specimens definitely
enhances the diagnostic value when assessing the post-
treatment H. pylori status [9].
Our aim was to assess the diagnostic value of different
non-invasive (13C-UBT) and endoscopy-based diagnostic
methods (visual endoscopy, classical cytological and his-
tological examination of mucosal specimens, PCR and
bacteriological methods) for monitoring patients after
eradication therapy in a late post-treatment setting.
Methods
Patients
The study group was formed of 134 consecutive peptic
ulcer outpatients who had been treated by 7-day triple
therapy with metronidazole, amoxicillin and omeprazole
in 1996. The group was observed at the outpatient depart-
ment of Tartu University Hospital at 4 weeks, at 1 year
(1997) and at 5 (2001) years after treatment [10]. Five
years after treatment, 108 patients (81% of the initial
group) were available for the follow-up of the clinical
course of peptic ulcer. During the 5-year follow-up period
only 11 (10 %) patients had relapses of peptic ulcer. For
comparison of the diagnostic value of different diagnostic
methods in a post-treatment setting, 34 patients were
recruited. The inclusion criteria for this study group were
resistant upper abdominal pain as the predominant com-
plaint and compliance with all investigations (clinical
symptoms,  13C-UBT, endoscopy, biopsy, bacteriology,
PCR and cytology). The studied patients were not NSAID
users.
Methods
The patients passed the Gastrointestinal Symptoms Rating
Scale (GSRS) test [11] in a validated Estonian translation.
Dyspeptic syndrome (abdominal pain, heartburn, acid
regurgitation, sucking sensation, nausea and vomiting)
was registered on the 7-grade Likert scale for assessing
severity of symptoms. The mean score of dyspeptic syn-
drome was calculated for each patient.
13C-UBT
The subjects passed 13C-UBT drinking 100 mg 13C-urea;
the test meal was citric acid and the time of specimen col-
lection was 30 min. The test was provided, according to a
standard protocol, from the Helsinki Keskuskatu Labora-
tory, Finland. The ratio of 13CO2 to  12CO2 in expired
breath was measured by mass spectrometry and expressed
in ml/mmol/kg (δ). An automated breath 13C analyser
(ABCA) with chromatographic purification and a single
inlet isotope ratio mass spectrometer (IRMS) were used. A
difference of 5‰ in the content (δ13C) was considered
positive for H. pylori infection.
Endoscopy of the upper gastrointestinal tract
The procedure was performed with the gastroscope Olym-
pus-GIF 21. All mucosal defects were registered according
to the Sydney classification for endoscopic evaluation
[12]. Gastric ulcer was diagnosed if the ulcer was located
at the angulus or above it. Duodenal ulcer was diagnosed
if the ulcer was found in the duodenal bulb area.
Gastrobiopsy and histological examination
Five specimens from the antrum mucosa and five from the
corpus mucosa were taken with medium-sized forceps.
Two specimens were embedded in paraffin and the paraf-
fin sections were stained using haematoxylin-eosin and
Giemsa methods. The mucosal specimens were evaluated
histologically according to the Sydney classification: pres-
ence of neutrophil infiltration, chronic lymphocytic
inflammation, surface epithelial damage, atrophy, intesti-
nal metaplasia, lymphoid follicles and H. pylori colonisa-
tion were evaluated on a three-grade scale both for the
antrum and the corpus [12-14].
Bacteriological examination
One specimen from the antrum and one from the corpus
were placed in the Stuart Transport Medium (Oxoid) and
taken to the laboratory within two hours for bacteriologi-
cal examination. The biopsy samples were homogenised
with sterile glass powder and under a stream of CO2 and
diluted in the Brucella broth (Oxoid). H. pylori was iso-
lated on the Columbia Agar Base supplemented with 7%
horse blood and 1% Vitox (Oxoid) or Isovitalex (BBL).
The plates were incubated for 3–7 days at 37°C under
microaerobic conditions (CampyBak, BBL or CampyGen,
Oxoid). H. pylori was identified by Gram staining and by
oxidase, catalase and urease reactions [15]. The sensitivity
of the isolated H. pylori strains to clarithromycin was esti-
mated by E-test. The antibiotic cut-off points employed
for the E-test were 1.0 mg/l (NCCLS, 2002).BMC Gastroenterology 2004, 4:27 http://www.biomedcentral.com/1471-230X/4/27
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Cytological examination
One specimen was used for imprinting the cytology slides
from the antrum and corpus mucosa, fixed with 96% eth-
anol and stained by Acridine Orange (Difco, BBL) [16].
The cytological specimens were studied under a fluores-
cence microscope (AXI Phot 2) where the morphotypes
and the density of bacterial colonisation were evaluated
[17]. A positive cytological diagnosis was based on the
presence of typical helical H. pylori cells on the gastric
mucosa and in the mucus layer.
PCR
For DNA extraction of H. pylori from a frozen gastric
biopsy specimen, a previously described procedure was
used [18]. The presence of the glmM gene in each strain
was established by PCR using primers, the reaction mix-
ture, and thermal cycling [19,20]. DNA from H. pylori
NCTC 11637 (National Collection of Type Cultures, Cen-
tral Public Health Laboratory, Colindale Ave., London
NW9 5HT, England, United Kingdom) and the DNA-free
reaction mixture were assayed in separate tubes in each
PCR and were run as the positive and negative controls of
the reaction, respectively. The PCR products were identi-
fied by electrophoresis on 2% agarose gels.
Criteria for evaluation
H. pylori was assessed positive if at least two tests were pos-
itive according to golden standard [21].
Statistical analysis
The data were analysed by Fisher's exact tests using the
Jandel SigmaStat 2.0 program. Measurements from the
GSRS were expressed as the mean values for dyspeptic
syndrome.
Ethics
The study was carried out in accordance with the Helsinki
Declaration and was approved by the Ethics Committee of
the University of Tartu.
Results
Dyspeptic syndrome was found in all 34 cases. The mean
GSRS score for the patients varied from 1.2 to 4.3.
The applied non-invasive test revealed H. pylori infection
in half of the investigated patients: positive 13C-UBT was
found in 17 out of 34 cases. There was no difference
between the mean GSRS score values for the H. pylori pos-
itive and negative cases (2.8 ± 1.8 vs. 2.9 ± 1.7, p > 0.05).
On endoscopy, among the 34 patients, no ulcer or other
mucosal defects were observed in 24 cases; erosions in the
duodenal bulb were revealed in 6 cases and peptic ulcer
was found in 4 cases (2 duodenal ulcers and 2 gastric
ulcers). The data of H. pylori status and of the endoscopic
finding are presented in Table 1.
A poor concordance was found between the visual exam-
ination of the gastric and duodenal mucosa on endoscopy
and the applied non-invasive and invasive tests of H. pylori
(accepting 13C-UBT, histological examination and PCR as
the reference tests). The gastric and duodenal mucosa was
visually normal in 11 H. pylori positive cases out of 17. On
the contrary, only in 4 H. pylori positive cases did the
endoscopic examination reveal the above mentioned pep-
tic ulcers. Among the 6 cases with erosions of the duode-
nal mucosa, only two patients were H. pylori positive.
Comparison of the different diagnostic methods used for
the detection of H. pylori is shown in Table 1. The results
of 13C-UBT and PCR were consistent with the data of his-
tological examination both in 17H. pylori positive and 17
negative cases. On bacteriological examination, only one
case, which was H. pylori positive both by PCR and the
histological tests, was H. pylori negative. In contrast, cyto-
logical examination assessed typical H. pylori bacterial
cells in only 4 of the 17H. pylori positive cases (24%),
while all other cases (both positive and negative for H.
pylori by the other methods) displayed abundant bacteria
of different morphotypes.
Table 1: Comparison of the findings in H. pylori positive and negative cases in a late post-treatment setting
Patients (n = 34) Non-invasive method
13C-UBT (+) n = 17 13C-UBT (-) n = 17
Invasive methods Endoscopy: Normal 11 13
Duodenal ulcer 2 0
Gastric ulcer 2 0
Erosions 2 4
Cytology: H. pylori (+) 4* Diverse forms of bacteria
Histology: H. pylori (+) 17 0
Bacteriology: H. pylori (+) 16 1
PCR: H. pylori (+) 17 0
* typical morphology of H. pylori (the other cases showing diverse forms of bacteria)BMC Gastroenterology 2004, 4:27 http://www.biomedcentral.com/1471-230X/4/27
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The data of the histological findings are presented in Table
2. Colonisation of the gastric mucosa by H. pylori was
detected in 17 patients out of 34. Neutrophil infiltration,
chronic inflammation, and surface epithelial damage
both in the antrum and corpus mucosa were significantly
expressed in the H. pylori positive cases (p < 0.001). Glan-
dular atrophy and intestinal metaplasia were rarely
observed both in the antrum and corpus mucosa of the H.
pylori negative cases in comparison with the H. pylori pos-
itive cases, but the difference was not statistically signifi-
cant (p > 0.05). Lymphoid follicles were more frequent in
the antrum colonised with H. pylori (p < 0.05).
Bacteriological investigation revealed H. pylori in 16
biopsy samples of the antral mucosa, while highly (> 256
mg/l) clarithromycin resistant H. pylori strains were found
in 3 cases.
Discussion
Proper diagnostic and therapeutic management of
patients with dyspeptic syndrome after H. pylori eradica-
tion therapy is of utmost importance for physicians as
well for patients [7]. Several studies [22,23] have demon-
strated the reliability of H. pylori tests used before treat-
ment, while post-treatment testing is not yet adequately
studied. However, in the case of long-lasting recurrent
dyspepsia after H. pylori eradication therapy, endoscopy
has been strongly recommended [4]. Our study shows
that endoscopy gives useful information for the general
practitioner both in the cases where peptic ulcer is found
and in the cases where it is not found. In the case of a nor-
mal endoscopic finding, further management depends on
the histological finding and on H. pylori status. Since per-
sistent H. pylori positivity is always associated with possi-
ble peptic ulcer recurrence, the second line treatment
according to bacterial susceptibility should be recom-
mended. In the remaining cases where H. pylori is absent,
the gastric mucosa is normal and no ulcer is detected,
management of such patients should be aimed at estab-
lishment of other possible reasons for their complaints.
Usually, a normal endoscopic finding reassures both the
doctor and the patient [7].
A recent study of Ohkusa et al. [24] showed that even sim-
ple careful visual evaluation of the mucosa and the diag-
noses of erythema and oedema correlated well with H.
pylori infection. On the contrary, our results demonstrate
that although all patients with recurrent peptic ulcer were
H. pylori positive, the minor visual findings in the other
cases were not in concordance with H. pylori colonisation.
Usually, the mucosa was visually normal even when H.
pylori was found, and, on the contrary, most duodenal
erosions occurred in H. pylori negative patients. The clini-
cal data of our patients did not suggest earlier use of
NSAID, which would have been one of the main reasons
for H. pylori negative erosions. Therefore, after treatment,
in presence of complaints, it is important to obtain sam-
ples for the investigation of gastric mucosa specimens to
enhance the value of endoscopic examination. We com-
pletely agree with the opinion that the value of using
mucosal specimens for histological evaluation of late
post-treatment H. pylori eradication is sometimes underes-
Table 2: Gastric mucosal findings (by the Sydney system) in H. pylori positive and negative cases
Gastric mucosal findings (Sydney system) H. pylori (+) n = 17 H. pylori (-) n = 17 p values
Activity of neutrophil polymorphs
Antrum 11/17 0/17 <0.001
Corpus 7/16 0/17 <0.05
Chronic inflammation
Antrum 16/17 1/17 <0.001
Corpus 13/16 0/17 <0.001
Surface epithelial damage
Antrum 13/17 0/17 <0.001
Corpus 8/16 0/17 <0.001
Glandular atrophy
Antrum 7/17 2/17 NS*
Corpus 4/16 3/17 NS
Intestinal metaplasia
Antrum 1/17 2/17 NS
Corpus 0/16 2/17 NS
Lymphoid follicles
Antrum 6/17 0/17 <0.05
Corpus 5/16 2/17 NS
* NS, not significant (p > 0.05).BMC Gastroenterology 2004, 4:27 http://www.biomedcentral.com/1471-230X/4/27
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timated [9]. The non-invasive H. pylori test alone cannot
solve the clinical problem of these patients. In our study,
H. pylori negative patients had dyspeptic syndrome as well
as gastric mucosal erosions, glandular atrophy and intes-
tinal metaplasia. The last two lesions can presumably be
associated with previous H. pylori infection and the fol-
low-up of severe mucosal changes is recommended [25].
Hence it is evident that follow-up strategy should be con-
sidered also in H. pylori negative cases in accordance with
endoscopic and histological findings.
Our study demonstrates that evaluation of the gastric
mucosa with a focus on neutrophil and lymphocyte infil-
tration and epithelial damage is specific and sensitive for
diagnosing H. pylori infection even after treatment, and
that the diagnostic value of a histology-based decision is
high. Today, the value of mucosal specimens for the post-
treatment histological diagnosis of H. pylori is considered
low assuming that H. pylori colonisation may be patchy,
or coccoid forms are difficult to detect [25]. We have
excluded patchy damage by using 13C-UBT  in parallel
with histological investigation.
Next, for detecting the coccoid forms of the bacteria, we
used additionally PCR method. Our results show that the
histological finding of H. pylori completely correlates with
the results of 13C-UBT and PCR both in H. pylori positive
and negative cases. This confirms the validity of the histo-
logical evaluation of mucosal specimens in the case of
recurrent peptic ulcer or erosions. Moreover, in countries
with a high rate of H. pylori infection and gastric cancer, it
is especially important to follow up patients for detecting
dysplasia and malignancies [26-29].
Surprisingly, brush cytology from the mucosa failed to
detect H. pylori in cases where it was found by other meth-
ods. Cytology is highly evaluated for detection of H. pylori
infection, as its agreement with histology is considered to
be 100% [30]. Our results show that when patients had
been treated with antibacterial drugs and still had dyspep-
tic complaints, cytological examination was not suitable
for H. pylori detection, as different forms of the bacteria
were found. The morphology of the helicobacters could
have been modified for coccoid or otherwise non-typical
forms. It is possible that some other bacteria might have
colonised the mucosa due to reduced colonisation resist-
ance after antibacterial treatment, failure of some intesti-
nal functions or usage of medicines administered to
relieve the feeling of discomfort [31-33].
Bacteriological investigation enabled to find a few clari-
thromycin resistant H. pylori strains, which may result in
the failure of repeat triple therapy. As the macrolide clari-
thromycin is chemically stable and well tolerated [34],
physicians often choose it for treatment of different infec-
tions. Therefore, if the physician plans to use macrolides,
endoscopy and histological testing should be accompa-
nied by bacteriological investigation. Regarding PCR, its
main value, obtaining of fast results, is evidently not so
important in post-treatment settings.
Conclusions
In a late post-treatment setting, patients with dyspepsia
should not be monitored only by non-invasive investiga-
tion methods; it is also justified to use the classical histo-
logical evaluation of H. pylori colonisation, PCR and
bacteriology as they have shown good concordance with
13C-UBT. Moreover, endoscopy and histological investiga-
tion of a gastric biopsy have proved to be the methods
with an additional diagnostic value, providing the physi-
cian with information about inflammatory, atrophic and
metaplastic lesions of the stomach in dyspeptic H. pylori
positive and negative patients. Bacteriological methods
are suggested for detecting the putative antimicrobial
resistance of H. pylori, aimed at successful eradication of
infection in persistent peptic ulcer cases.
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